0001209191-21-002834.txt : 20210108 0001209191-21-002834.hdr.sgml : 20210108 20210108193026 ACCESSION NUMBER: 0001209191-21-002834 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210106 FILED AS OF DATE: 20210108 DATE AS OF CHANGE: 20210108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIM AUSTIN D. CENTRAL INDEX KEY: 0001746240 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 21518786 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 12830 EL CAMINO REAL, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-06 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001746240 KIM AUSTIN D. C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130 0 1 0 0 EVP & General Counsel Common Stock 2021-01-06 4 M 0 1633 A 6196 D Common Stock 2021-01-06 4 S 0 678 53.34 D 5518 D Restricted Stock Units 2021-01-06 4 M 0 1633 0.00 D Common Stock 1633 4900 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Includes 712 shares of the Issuer's common stock acquired by the reporting person on November 13, 2020 pursuant to an employee stock purchase program. The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in four equal annual installments beginning January 6, 2021. /s/ Austin D. Kim, Attorney-in-Fact 2021-01-08